| dna metabolic process | GO:0006259 | 303 | 1.000 | |
| dna repair | GO:0006281 | 107 | 1.000 | Human |
| dna recombination | GO:0006310 | 92 | 1.000 | Human |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 1.000 | |
| meiotic cell cycle | GO:0051321 | 122 | 1.000 | |
| meiotic cell cycle process | GO:1903046 | 77 | 1.000 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 1.000 | |
| double strand break repair | GO:0006302 | 48 | 0.999 | Human |
| response to ionizing radiation | GO:0010212 | 42 | 0.999 | Human |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.999 | |
| recombinational repair | GO:0000725 | 21 | 0.999 | Human |
| meiosis i | GO:0007127 | 60 | 0.998 | |
| male meiosis i | GO:0007141 | 16 | 0.997 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.996 | Human |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.996 | |
| meiotic chromosome segregation | GO:0045132 | 19 | 0.996 | |
| double strand break repair via homologous recombination | GO:0000724 | 21 | 0.996 | Human |
| reciprocal dna recombination | GO:0035825 | 16 | 0.995 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.994 | Human |
| regulation of cell cycle | GO:0051726 | 281 | 0.993 | Human |
| meiotic nuclear division | GO:0007126 | 115 | 0.993 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.991 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.990 | |
| regulation of cell division | GO:0051302 | 76 | 0.989 | |
| nuclear division | GO:0000280 | 158 | 0.988 | |
| response to radiation | GO:0009314 | 165 | 0.985 | Human |
| female meiosis chromosome segregation | GO:0016321 | 1 | 0.983 | |
| organelle fission | GO:0048285 | 170 | 0.982 | |
| reciprocal meiotic recombination | GO:0007131 | 16 | 0.982 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.978 | |
| spermatogenesis | GO:0007283 | 284 | 0.976 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.975 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.974 | |
| dna replication | GO:0006260 | 52 | 0.973 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.965 | Human |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.964 | |
| mitotic g2 dna damage checkpoint | GO:0007095 | 8 | 0.964 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.964 | |
| cellular response to ionizing radiation | GO:0071479 | 11 | 0.964 | |
| dna conformation change | GO:0071103 | 37 | 0.960 | |
| regionalization | GO:0003002 | 337 | 0.959 | |
| telomere maintenance | GO:0000723 | 19 | 0.958 | |
| cell division | GO:0051301 | 120 | 0.951 | |
| centrosome cycle | GO:0007098 | 23 | 0.951 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.947 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.943 | Human |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.937 | |
| histone acetylation | GO:0016573 | 41 | 0.937 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.930 | Human |
| cell aging | GO:0007569 | 35 | 0.928 | |
| cell cycle arrest | GO:0007050 | 37 | 0.927 | Human |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.925 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.925 | |
| male meiosis | GO:0007140 | 37 | 0.923 | |
| regulation of mitosis | GO:0007088 | 29 | 0.918 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.917 | Human |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.914 | |
| chromosome segregation | GO:0007059 | 48 | 0.913 | Human |
| signal transduction involved in dna integrity checkpoint | GO:0072401 | 3 | 0.912 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.905 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.904 | Human |
| negative regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0071930 | 1 | 0.901 | |
| microtubule organizing center organization | GO:0031023 | 28 | 0.898 | |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 19 | 0.896 | |
| blastocyst growth | GO:0001832 | 23 | 0.896 | |
| chromatin organization | GO:0006325 | 206 | 0.895 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.891 | |
| centrosome organization | GO:0051297 | 26 | 0.887 | |
| signal transduction involved in mitotic dna integrity checkpoint | GO:1902403 | 3 | 0.884 | |
| signal transduction involved in dna damage checkpoint | GO:0072422 | 3 | 0.883 | |
| response to light stimulus | GO:0009416 | 135 | 0.882 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.875 | |
| mitotic sister chromatid cohesion | GO:0007064 | 1 | 0.872 | |
| response to uv | GO:0009411 | 44 | 0.862 | |
| response to caffeine | GO:0031000 | 6 | 0.861 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 16 | 0.856 | |
| negative regulation of mammary gland epithelial cell proliferation | GO:0033600 | 3 | 0.848 | |
| g2 dna damage checkpoint | GO:0031572 | 8 | 0.848 | Human |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.840 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.837 | |
| cellular response to radiation | GO:0071478 | 28 | 0.825 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.823 | |
| cell cycle g2 m phase transition | GO:0044839 | 20 | 0.821 | |
| response to x ray | GO:0010165 | 11 | 0.816 | |
| female meiotic division | GO:0007143 | 21 | 0.814 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.814 | Human |
| chromatin modification | GO:0016568 | 187 | 0.806 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.801 | |
| replication fork protection | GO:0048478 | 1 | 0.794 | |
| dna catabolic process exonucleolytic | GO:0000738 | 3 | 0.788 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.778 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.771 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.763 | |
| dna catabolic process | GO:0006308 | 19 | 0.763 | |
| dna packaging | GO:0006323 | 30 | 0.761 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.758 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.747 | |
| protein catabolic process | GO:0030163 | 221 | 0.737 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.730 | |
| dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator | GO:0006978 | 2 | 0.726 | |
| non recombinational repair | GO:0000726 | 10 | 0.719 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.713 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.711 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.706 | Human |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.703 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.695 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.694 | Human |
| oocyte differentiation | GO:0009994 | 35 | 0.689 | |
| protein acylation | GO:0043543 | 64 | 0.683 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.665 | |
| regulation of dna replication | GO:0006275 | 17 | 0.662 | |
| mitotic sister chromatid segregation | GO:0000070 | 14 | 0.658 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.655 | |
| cytokinesis | GO:0000910 | 17 | 0.651 | |
| regulation of cytokinesis | GO:0032465 | 5 | 0.651 | |
| germ cell development | GO:0007281 | 185 | 0.648 | |
| female gamete generation | GO:0007292 | 74 | 0.645 | |
| male gamete generation | GO:0048232 | 285 | 0.641 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.634 | |
| positive regulation of histone methylation | GO:0031062 | 16 | 0.633 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.618 | |
| dna dependent dna replication | GO:0006261 | 24 | 0.618 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.603 | |
| mitochondrial dna repair | GO:0043504 | 3 | 0.582 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.566 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 20 | 0.557 | |
| centrosome duplication | GO:0051298 | 16 | 0.553 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.553 | |
| oocyte development | GO:0048599 | 33 | 0.551 | |
| translesion synthesis | GO:0019985 | 1 | 0.549 | |
| mammary gland epithelial cell proliferation | GO:0033598 | 24 | 0.542 | |
| negative regulation of nuclear division | GO:0051784 | 19 | 0.536 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.534 | Human |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.533 | |
| histone methylation | GO:0016571 | 71 | 0.525 | |
| telomere capping | GO:0016233 | 4 | 0.524 | |
| protein methylation | GO:0006479 | 81 | 0.523 | |
| somatic diversification of immunoglobulins involved in immune response | GO:0002208 | 36 | 0.521 | |
| mitotic spindle assembly checkpoint | GO:0007094 | 7 | 0.521 | |
| oogenesis | GO:0048477 | 56 | 0.511 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.508 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 17 | 0.502 | |
| microtubule based process | GO:0007017 | 236 | 0.498 | |
| replicative senescence | GO:0090399 | 2 | 0.497 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.492 | |
| response to alkaloid | GO:0043279 | 34 | 0.492 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.488 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.477 | |
| blastocyst development | GO:0001824 | 80 | 0.468 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.467 | |
| response to purine containing compound | GO:0014074 | 28 | 0.458 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.457 | |
| signal transduction involved in mitotic cell cycle checkpoint | GO:0072413 | 3 | 0.455 | |
| chromosome condensation | GO:0030261 | 10 | 0.454 | |
| chromosome organization involved in meiosis | GO:0070192 | 39 | 0.446 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.444 | |
| metaphase anaphase transition of mitotic cell cycle | GO:0007091 | 9 | 0.441 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.432 | |
| response to gamma radiation | GO:0010332 | 22 | 0.431 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.431 | |
| intra s dna damage checkpoint | GO:0031573 | 4 | 0.428 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.426 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.413 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.412 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 3 | 0.412 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.409 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.400 | |
| regulation of g2 m transition of mitotic cell cycle | GO:0010389 | 10 | 0.398 | |
| oocyte maturation | GO:0001556 | 18 | 0.396 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.396 | |
| negative regulation of dna dependent dna replication | GO:2000104 | 1 | 0.391 | |
| regulation of mitotic sister chromatid segregation | GO:0033047 | 12 | 0.388 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.387 | |
| digestive tract development | GO:0048565 | 190 | 0.386 | |
| dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest | GO:0006977 | 3 | 0.383 | |
| mitotic recombination | GO:0006312 | 3 | 0.379 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.372 | |
| organelle assembly | GO:0070925 | 177 | 0.365 | |
| sister chromatid segregation | GO:0000819 | 20 | 0.362 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.359 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.358 | |
| inner cell mass cell proliferation | GO:0001833 | 15 | 0.357 | |
| axonogenesis | GO:0007409 | 274 | 0.356 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.349 | Human Rat |
| dna biosynthetic process | GO:0071897 | 22 | 0.349 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.348 | |
| dna damage response signal transduction resulting in transcription | GO:0042772 | 2 | 0.345 | |
| attachment of spindle microtubules to kinetochore | GO:0008608 | 4 | 0.345 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.337 | Human |
| metaphase plate congression | GO:0051310 | 2 | 0.336 | |
| regulation of metaphase anaphase transition of cell cycle | GO:1902099 | 9 | 0.334 | |
| cellular response to light stimulus | GO:0071482 | 19 | 0.330 | |
| intracellular signal transduction involved in g1 dna damage checkpoint | GO:1902400 | 3 | 0.315 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.314 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.313 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.308 | |
| microtubule cytoskeleton organization involved in mitosis | GO:1902850 | 4 | 0.304 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.299 | |
| cohesin localization to chromatin | GO:0071921 | 1 | 0.295 | |
| histone lysine methylation | GO:0034968 | 50 | 0.291 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.289 | |
| negative regulation of cell division | GO:0051782 | 24 | 0.283 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.282 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.281 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.278 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.275 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.275 | |
| regulation of chromosome segregation | GO:0051983 | 21 | 0.275 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.274 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.272 | |
| gene silencing | GO:0016458 | 38 | 0.270 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.262 | |
| dna duplex unwinding | GO:0032508 | 7 | 0.260 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.260 | |
| dna geometric change | GO:0032392 | 7 | 0.258 | |
| macromolecule methylation | GO:0043414 | 120 | 0.257 | |
| mitotic sister chromatid separation | GO:0051306 | 9 | 0.257 | |
| regulation of protein localization | GO:0032880 | 231 | 0.256 | |
| regulation of cohesin localization to chromatin | GO:0071922 | 1 | 0.254 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.253 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.252 | |
| maintenance of location | GO:0051235 | 89 | 0.251 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.249 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.247 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.247 | |
| regulation of dna dependent dna replication | GO:0090329 | 8 | 0.241 | |
| regulation of microtubule based process | GO:0032886 | 52 | 0.240 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.239 | |
| regulation of binding | GO:0051098 | 111 | 0.238 | |
| regulation of mammary gland epithelial cell proliferation | GO:0033599 | 12 | 0.238 | |
| double strand break repair via nonhomologous end joining | GO:0006303 | 10 | 0.232 | |
| chromatin silencing | GO:0006342 | 15 | 0.227 | |
| mitotic g1 dna damage checkpoint | GO:0031571 | 4 | 0.227 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.227 | |
| b cell activation | GO:0042113 | 161 | 0.222 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.222 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.221 | |
| negative regulation of cell cycle arrest | GO:0071157 | 1 | 0.220 | |
| positive regulation of g2 m transition of mitotic cell cycle | GO:0010971 | 5 | 0.216 | |
| b cell proliferation | GO:0042100 | 53 | 0.208 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.206 | |
| atp catabolic process | GO:0006200 | 55 | 0.203 | |
| gland development | GO:0048732 | 330 | 0.202 | |
| signal transduction in response to dna damage | GO:0042770 | 21 | 0.201 | |
| negative regulation of g1 s transition of mitotic cell cycle | GO:2000134 | 18 | 0.200 | |
| female gonad development | GO:0008585 | 71 | 0.200 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.195 | |
| regulation of protein stability | GO:0031647 | 52 | 0.192 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.192 | |
| gonad development | GO:0008406 | 141 | 0.192 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.191 | Human |
| t cell receptor v d j recombination | GO:0033153 | 5 | 0.188 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.187 | |
| neuron migration | GO:0001764 | 122 | 0.186 | |
| histone h3 k9 methylation | GO:0051567 | 17 | 0.185 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.184 | |
| protein oligomerization | GO:0051259 | 67 | 0.184 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.183 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.182 | |
| regulation of mitotic metaphase anaphase transition | GO:0030071 | 8 | 0.180 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.178 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.176 | Human |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.176 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.175 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.174 | |
| histone modification | GO:0016570 | 159 | 0.173 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.173 | |
| response to metal ion | GO:0010038 | 47 | 0.167 | |
| positive regulation of mitotic sister chromatid separation | GO:1901970 | 2 | 0.166 | |
| protein localization to chromatin | GO:0071168 | 3 | 0.165 | |
| t cell activation | GO:0042110 | 289 | 0.162 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.162 | |
| germline cell cycle switching mitotic to meiotic cell cycle | GO:0051729 | 1 | 0.161 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.159 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.158 | |
| response to uv c | GO:0010225 | 3 | 0.157 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.155 | |
| negative regulation of mitotic sister chromatid segregation | GO:0033048 | 7 | 0.155 | |
| dna endoreduplication | GO:0042023 | 4 | 0.154 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.151 | |
| protein ubiquitination | GO:0016567 | 171 | 0.149 | Human |
| regulation of sister chromatid cohesion | GO:0007063 | 5 | 0.149 | |
| actin filament organization | GO:0007015 | 113 | 0.149 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.146 | |
| dendrite development | GO:0016358 | 115 | 0.145 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.145 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.144 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.143 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.143 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.143 | Human |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.143 | |
| isotype switching | GO:0045190 | 36 | 0.143 | |
| female sex differentiation | GO:0046660 | 84 | 0.142 | |
| positive regulation of response to dna damage stimulus | GO:2001022 | 14 | 0.142 | Human |
| spindle assembly involved in mitosis | GO:0090307 | 4 | 0.140 | |
| negative regulation of cellular senescence | GO:2000773 | 3 | 0.140 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.139 | |
| negative regulation of mitotic metaphase anaphase transition | GO:0045841 | 7 | 0.138 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.136 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.135 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.135 | |
| intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator | GO:0042771 | 24 | 0.134 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.133 | |
| positive regulation of chromosome segregation | GO:0051984 | 4 | 0.132 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.131 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.130 | |
| positive regulation of protein autophosphorylation | GO:0031954 | 4 | 0.130 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.130 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.130 | |
| amine metabolic process | GO:0009308 | 45 | 0.128 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.128 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.126 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.126 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.123 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.122 | |
| regulation of histone modification | GO:0031056 | 56 | 0.121 | |
| synapsis | GO:0007129 | 34 | 0.119 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.119 | |
| regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032434 | 40 | 0.117 | |
| spindle checkpoint | GO:0031577 | 12 | 0.115 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.114 | Human |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.112 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.111 | |
| negative regulation of cell cycle g1 s phase transition | GO:1902807 | 18 | 0.111 | |
| digestive system development | GO:0055123 | 200 | 0.109 | |
| mitotic cell cycle arrest | GO:0071850 | 4 | 0.109 | |
| b cell lineage commitment | GO:0002326 | 4 | 0.109 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.109 | |
| positive regulation of mitotic metaphase anaphase transition | GO:0045842 | 2 | 0.106 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.106 | |
| stem cell development | GO:0048864 | 219 | 0.105 | |
| spindle organization | GO:0007051 | 28 | 0.103 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.101 | |
| regulation of attachment of spindle microtubules to kinetochore | GO:0051988 | 3 | 0.101 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.101 | |
| cell fate commitment | GO:0045165 | 210 | 0.101 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.101 | Human |
| dna ligation | GO:0006266 | 3 | 0.100 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.098 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.098 | |
| pole plasm assembly | GO:0007315 | 2 | 0.097 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.097 | |
| t cell proliferation | GO:0042098 | 120 | 0.095 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.094 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.094 | |
| regulation of sister chromatid segregation | GO:0033045 | 13 | 0.093 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.092 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.092 | |
| negative regulation of mitotic sister chromatid separation | GO:2000816 | 7 | 0.091 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.088 | |
| atp metabolic process | GO:0046034 | 75 | 0.088 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.088 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.087 | Human |
| cell growth | GO:0016049 | 130 | 0.087 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.087 | |
| nucleotide excision repair | GO:0006289 | 13 | 0.087 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.086 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.085 | |
| regulation of mitotic sister chromatid separation | GO:0010965 | 12 | 0.085 | |
| somatic recombination of immunoglobulin genes involved in immune response | GO:0002204 | 36 | 0.083 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.083 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.083 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.081 | |
| negative regulation of lipid kinase activity | GO:0090219 | 1 | 0.081 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.080 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.079 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.079 | |
| developmental maturation | GO:0021700 | 193 | 0.079 | |
| negative regulation of sister chromatid segregation | GO:0033046 | 7 | 0.076 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.076 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.075 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.074 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.074 | |
| methylation | GO:0032259 | 134 | 0.074 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.073 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.073 | |
| stem cell differentiation | GO:0048863 | 268 | 0.073 | |
| adaptive immune response | GO:0002250 | 155 | 0.072 | |
| rna localization | GO:0006403 | 23 | 0.071 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.071 | |
| negative regulation of mitosis | GO:0045839 | 10 | 0.070 | |
| sister chromatid cohesion | GO:0007062 | 12 | 0.070 | |
| negative regulation of growth | GO:0045926 | 99 | 0.070 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.070 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.070 | Human |
| histone threonine phosphorylation | GO:0035405 | 1 | 0.069 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.069 | |
| negative regulation of cyclin dependent protein serine threonine kinase activity | GO:0045736 | 9 | 0.069 | |
| regulation of meiosis i | GO:0060631 | 7 | 0.069 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.068 | |
| phosphatidylinositol 3 phosphate biosynthetic process | GO:0036092 | 6 | 0.068 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.068 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.067 | |
| membrane organization | GO:0061024 | 245 | 0.067 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.067 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.067 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.067 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.067 | |
| positive regulation of growth | GO:0045927 | 104 | 0.066 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.066 | |
| base excision repair | GO:0006284 | 9 | 0.066 | |
| signal transduction involved in cell cycle checkpoint | GO:0072395 | 3 | 0.065 | |
| multicellular organism growth | GO:0035264 | 161 | 0.065 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.064 | |
| centriole assembly | GO:0098534 | 6 | 0.064 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.063 | |
| spindle assembly involved in female meiosis | GO:0007056 | 3 | 0.063 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.062 | |
| chromatin assembly | GO:0031497 | 13 | 0.062 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.062 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.061 | |
| negative regulation of b cell activation | GO:0050869 | 27 | 0.061 | |
| cerebrospinal fluid secretion | GO:0033326 | 4 | 0.061 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.061 | |
| spindle assembly | GO:0051225 | 13 | 0.061 | |
| astral microtubule organization | GO:0030953 | 3 | 0.060 | |
| mitotic spindle organization | GO:0007052 | 10 | 0.060 | |
| histone mrna metabolic process | GO:0008334 | 3 | 0.060 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.060 | |
| t cell differentiation | GO:0030217 | 174 | 0.060 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.060 | |
| negative regulation of metaphase anaphase transition of cell cycle | GO:1902100 | 8 | 0.060 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.060 | |
| regulation of microtubule depolymerization | GO:0031114 | 13 | 0.060 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.059 | |
| traversing start control point of mitotic cell cycle | GO:0007089 | 2 | 0.058 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.058 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.058 | |
| regulation of protein depolymerization | GO:1901879 | 26 | 0.058 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.057 | |
| dna hypermethylation | GO:0044026 | 3 | 0.057 | |
| negative regulation of protein catabolic process | GO:0042177 | 36 | 0.057 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.056 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.056 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.056 | |
| regulation of cell activation | GO:0050865 | 289 | 0.056 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.056 | |
| dna replication checkpoint | GO:0000076 | 2 | 0.055 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.055 | |
| mitochondrion organization | GO:0007005 | 134 | 0.055 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.055 | |
| regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0000083 | 3 | 0.055 | |
| somatic diversification of t cell receptor genes | GO:0002568 | 5 | 0.054 | |
| positive regulation of histone h3 k27 methylation | GO:0061087 | 4 | 0.054 | |
| immune effector process | GO:0002252 | 321 | 0.053 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.052 | |
| organelle localization | GO:0051640 | 179 | 0.052 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.052 | Human |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.052 | |
| positive regulation of transcription by galactose | GO:0000411 | 1 | 0.051 | |
| regulation of neuron death | GO:1901214 | 134 | 0.050 | |
| regulation of microtubule cytoskeleton organization | GO:0070507 | 37 | 0.050 | |
| negative regulation of immature t cell proliferation | GO:0033087 | 3 | 0.050 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.050 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.049 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.049 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.049 | |
| regulation of protein binding | GO:0043393 | 60 | 0.048 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.048 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.048 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.047 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.047 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.047 | |
